GLP-1 therapies and the longevity movement are transforming consumer behavior, redefining nutrition, and reshaping demand across the global food system. For CTOs, this shift goes beyond market demand. It requires fundamentally new technologies, scaling protein production, AI-enabled rapid ingredient reformulation, and mastering the stability, taste, texture and label of nutrient-dense foods such as high protein foods. This session explores the technical frameworks and bio-manufacturing innovations driving the most significant shift in health-first food technology in decades.
